7:00 am |
Registration, Continental Breakfast and Exhibits
|
7:50 am |
Welcome and Introductions
Alex A. Adjei, MD, PhD |
|
Updates and State of the Art Therapy in Hematologic Malignancies
Co-Chairs: Marcelo Pasquini, MD, MS; Kathy Fu, MD |
8:00 am |
Management of Up-Front Therapy of Diffuse Large B Cell Lymphoma (DLBCL): Initial Therapy Considerations
Brian Hill, MD, PhD; Taylor Brooks, MD |
8:35 am |
Changing Landscape in Multiple Myeloma: Bispecific vs. CAR-T Therapy
Chakra Chaulagain, MD; Marcelo Pasquini, MD, MS |
9:10 am |
AML Induction Controversies: HMA- vs. Chemotherapy-Based Regimens
Moaath Mustafa Ali, MD |
9:30 am |
Audience Q&A
|
9:45 am |
Coffee Break and Exhibits
|
|
Genomics/Precision Oncology
Co-Chairs: Jacob Miller, MD; Elizabeth Azzato, MD, PhD |
10:15 am |
Precision Oncology in CNS and Pediatric Neoplasms: Tissue Genomics and CSF Diagnostics
Prajwal Rajappa, MD, MS |
10:35 am |
Applications of Digital Pathology for Diagnosis and Biomarker Discovery
Daniel Roberts, MD |
10:55 am |
The Impact of Clonal Hematopoiesis on cfDNA Diagnostics, Second Malignant Neoplasms, and Therapy Response
Abhay Singh, MD, MPH |
11:15 am |
Precision Oncology for Urothelial Malignancies: Biomarker-Adapted Therapy and Noninvasive Diagnostics
Laura Bukavina, MD, MPH |
11:35 am |
Case Presentations & Panel Discussion
|
12:15 pm |
Lunch, Exhibits and Non-CME Satellites
|
|
Updates and State of the Art Therapy in Lung Cancer
Co-Chairs: Moussa Sissoko, MD; James Stevenson, MD |
1:15 pm |
Surgical Management of Early-Stage NSCLC: Selection of Patients for Neoadjuvant Therapy
Edward Savage, MD |
1:35 pm |
Neoadjuvant and Adjuvant Therapy for Early-Stage NSCLC
Evan Alley, MD |
1:55 pm |
Update on Targeted Therapies for Driver-Mutated NSCLC
Michael Menefee, MD |
2:15 pm |
Role of Radiotherapy as Consolidation and in Treating Oligometastatic NSCLC
Kevin Stephans, MD |
2:35 pm |
Case Presentations & Panel Discussion
|
3:15 pm |
Adjourn
|
5:00 pm |
Welcome Reception
|